| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0165-5728(99)00259-3 |
| P698 | PubMed publication ID | 10713351 |
| P2093 | author name string | D Papanastasiou | |
| S J Tzartos | |||
| K Poulas | |||
| A Kokla | |||
| P2860 | cites work | Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis | Q69091652 |
| Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera | Q69139840 | ||
| 29 Production and assay of antibodies to acetylcholine receptors | Q71049501 | ||
| Characterisation, crystallisation and preliminary X-ray diffraction analysis of a Fab fragment of a rat monoclonal antibody with very high affinity for the human muscle acetylcholine receptor | Q71426806 | ||
| Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor | Q71763580 | ||
| Pharmacokinetics and organ distribution of cationized colchicine-specific IgG and Fab fragments in rat | Q77752302 | ||
| Myasthenia gravis | Q93537362 | ||
| Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit | Q33568995 | ||
| Gel filtration: a method for desalting and group separation | Q34246481 | ||
| A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. | Q34460958 | ||
| The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody | Q36080676 | ||
| Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies | Q36275255 | ||
| Crystallization and preliminary crystallographic study of an Fab fragment of a pathogenic rat monoclonal antibody against the nicotinic acetylcholine receptor. | Q36277683 | ||
| Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs | Q36358130 | ||
| Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies | Q36359851 | ||
| Design of yeast-secreted albumin derivatives for human therapy: biological and antiviral properties of a serum albumin-CD4 genetic conjugate | Q36868245 | ||
| Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG | Q37001311 | ||
| Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor | Q38323531 | ||
| High affinity single-chain Fv antibody fragments protecting the human nicotinic acetylcholine receptor | Q38323537 | ||
| Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenic sera | Q41759155 | ||
| Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice | Q42936967 | ||
| Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol | Q46157342 | ||
| Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors | Q46803307 | ||
| Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor | Q47700102 | ||
| Autoimmune Response to Acetylcholine Receptor | Q47996933 | ||
| Bacterial expression of a single-chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies | Q48108093 | ||
| Nicotinic acetylcholine receptor at 4.6 A resolution: transverse tunnels in the channel wall | Q50146671 | ||
| Growth hormone-albumin conjugates Reduced renal toxicity and altered plasma clearance | Q59540824 | ||
| Myasthenia Gravis: Passive Transfer from Man to Mouse | Q67318954 | ||
| Myasthenic Antibodies Cross-Link Acetylcholine Receptors to Accelerate Degradation | Q67320379 | ||
| Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor | Q68033058 | ||
| Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor | Q68821017 | ||
| Interaction between AChR-specific T- and B-line lymphocytes: antigen presentation by B hybridoma cells and the enhancing effect of monoclonal antibodies on T-cell activation | Q68834074 | ||
| P433 | issue | 2 | |
| P921 | main subject | myasthenia gravis | Q8285 |
| monoclonal antibody | Q422248 | ||
| P304 | page(s) | 124-132 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Prevention of passively transferred experimental autoimmune myasthenia gravis by Fab fragments of monoclonal antibodies directed against the main immunogenic region of the acetylcholine receptor | |
| P478 | volume | 104 |
| Q42656803 | Analysis of peripheral B cells and autoantibodies against the anti-nicotinic acetylcholine receptor derived from patients with myasthenia gravis using single-cell manipulation tools |
| Q43789079 | Conjugation of acetylcholine receptor-protecting Fab fragments with polyethylene glycol results in a prolonged half-life in the circulation and reduced immunogenicity |
| Q27632866 | Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies |
| Q35738827 | Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs |
| Q35708842 | Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes |
| Q37409458 | MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. |
| Q44528925 | Prevention of passively transferred experimental autoimmune myasthenia gravis by an in vitro selected RNA aptamer |
| Q34831033 | The role of antibodies in myasthenia gravis |
| Q35520740 | Update on myasthenia gravis |
Search more.